Atlas Trials

Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma

Clinical trial NCT07497607 · RECRUITING

Trial details

NCT number
NCT07497607
Sponsor
Sara Medek
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Oropharyngeal Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Start date
2026-05-13
Primary completion
2031-05-13
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.